New hope for tough bladder cancers: trial tests drug to extend life
NCT ID NCT07419295
Summary
This study is for people with advanced bladder cancer that has continued to grow despite previous treatments. Researchers want to see if a new drug called sacituzumab tirumotecan helps patients live longer compared to standard non-platinum chemotherapy options. About 590 participants will be randomly assigned to receive either the new drug or one of the standard chemotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.